LPCN - Lipocine Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development8,076.05312,580.24515,479.446
Selling General and Administrative10,382.1465,801.8235,001.368
Non Recurring728.635728.635728.635
Total Operating Expenses---
Operating Income or Loss-19,186.834-18,382.068-20,480.814
Income from Continuing Operations
Total Other Income/Expenses Net216.078173.89108.338
Earnings Before Interest and Taxes-18,970.756-18,208.178-20,372.476
Interest Expense---
Income Before Tax-18,970.756-18,208.178-20,372.476
Income Tax Expense0.7520.20.2
Minority Interest---
Net Income From Continuing Ops-18,971.508-18,208.378-20,372.676
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-18,971.508-18,208.378-20,372.676
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-18,971.508-18,208.378-20,372.676